Endurant Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History

Endurant Capital Management’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,949	Closed	-$1.08M	–	80
2022 Q1	$1.08M	Buy	20,949 +3,057	+17%	+$135K	0.29%	53
2021 Q4	$1.05M	Sell	17,892 -23,017	-56%	-$1.72M	0.25%	58
2021 Q3	$4.12M	Sell	40,909 -8,959	-18%	-$924K	0.94%	29
2021 Q2	$5.85M	Buy	49,868 +2,577	+5%	+$337K	1.61%	23
2021 Q1	$8.95M	Buy	47,291 +1,875	+4%	+$329K	2.33%	16
2020 Q4	$6.4M	Buy	45,416 +17,230	+61%	+$2.55M	2.31%	14
2020 Q3	$4.62M	Buy	28,186 +12,865	+84%	+$2.29M	1.37%	25
2020 Q2	$3.17M	Buy	+15,321	New	+$3.56M	0.17%	32

Other funds holding MTEM

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Endurant Capital Management's MTEM Position: Q2 2022 in Review

Endurant Capital Management sold out of Molecular Templates, Inc. (MTEM) in Q2 2022, closing a stake of 20,949 shares — an estimated $1.08M sold.

Endurant Capital Management first reported a position in MTEM in Q2 2020 and held it in 8 quarters. The position peaked at $8.95M in Q1 2021. 65 funds tracked by Wall St. Rank hold MTEM as of Q2 2022.

Endurant Capital Management reported no remaining Molecular Templates, Inc. position as of Q2 2022 after selling out during the quarter.
Endurant Capital Management sold 20,949 Molecular Templates, Inc. shares in Q2 2022, an estimated $1.08M.
Endurant Capital Management first reported a position in Molecular Templates, Inc. in Q2 2020 and held it in 8 quarters.
Endurant Capital Management's Molecular Templates, Inc. position peaked at $8.95M in Q1 2021.
65 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2022.

Based on Endurant Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.